HK, US stocks top stories
"Game +" cross-industry integration opens up new space for the industryGRANDPHARMA's conjugate drug TLX591-CDx has reached its primary clinical endpointCENTRALCHINA MT's resumption guidance has been fulfilled, and the shares have resumed tradingThe public offering of BENQ HOLDING was subscribed 6.28 times, with a 50% chance of winning one lotCSPC PHARMA's innovative drug SYH2085 has been approved to conduct clinical trialsThe public offering of B&K CORP-B received 791.95 times subscription, with a 2.5% chance of winning one lotCHINFMINING increased its stake in SM Minerals for a consideration of USD 89 millionQINGLING MOTORS repurchased new energy vehicles for a maximum price of 49.84 million RMBTONGGUAN GOLD issues new shares to fully purchase engineering service providers, involving an investment of 286 millionCIRC's subsidiary's application for clinical trials of improved new drugs has been approved